These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18497084)

  • 1. Membrane initiated signaling by 1,25alpha-dihydroxyvitamin D3 in LNCaP prostate cancer cells.
    Larsson D; Hagberg M; Malek N; Kjellberg C; Senneberg E; Tahmasebifar N; Johansson V
    Adv Exp Med Biol; 2008; 617():573-9. PubMed ID: 18497084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.
    Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C
    Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma.
    Wu W; Zhang X; Zanello LP
    Cancer Lett; 2007 Aug; 254(1):75-86. PubMed ID: 17412493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jun N-terminal kinase pathway enhances signaling of monocytic differentiation of human leukemia cells induced by 1,25-dihydroxyvitamin D3.
    Wang Q; Wang X; Studzinski GP
    J Cell Biochem; 2003 Aug; 89(6):1087-101. PubMed ID: 12898508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells.
    Swamy N; Chen TC; Peleg S; Dhawan P; Christakos S; Stewart LV; Weigel NL; Mehta RG; Holick MF; Ray R
    Clin Cancer Res; 2004 Dec; 10(23):8018-27. PubMed ID: 15585637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
    Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells.
    Stewart LV; Lyles B; Lin MF; Weigel NL
    J Steroid Biochem Mol Biol; 2005 Oct; 97(1-2):37-46. PubMed ID: 16076555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D.
    Nonn L; Peng L; Feldman D; Peehl DM
    Cancer Res; 2006 Apr; 66(8):4516-24. PubMed ID: 16618780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer.
    Joo SS; Yoo YM
    J Pineal Res; 2009 Aug; 47(1):8-14. PubMed ID: 19522739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular action of 1,25-dihydroxyvitamin D3 and phorbol ester on the activation of the rat cytochrome P450C24 (CYP24) promoter: role of MAP kinase activities and identification of an important transcription factor binding site.
    Nutchey BK; Kaplan JS; Dwivedi PP; Omdahl JL; Ferrante A; May BK; Hii CS
    Biochem J; 2005 Aug; 389(Pt 3):753-62. PubMed ID: 15836435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation between antioxidants and 1,25-dihydroxyvitamin D3 in induction of leukemia HL60 cell differentiation through the JNK/AP-1/Egr-1 pathway.
    Wang Q; Salman H; Danilenko M; Studzinski GP
    J Cell Physiol; 2005 Sep; 204(3):964-74. PubMed ID: 15799027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate derived factor in human prostate cancer cells: gene induction by vitamin D via a p53-dependent mechanism and inhibition of prostate cancer cell growth.
    Lambert JR; Kelly JA; Shim M; Huffer WE; Nordeen SK; Baek SJ; Eling TE; Lucia MS
    J Cell Physiol; 2006 Sep; 208(3):566-74. PubMed ID: 16741990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saposin C stimulates growth and invasion, activates p42/44 and SAPK/JNK signaling pathways of MAPK and upregulates uPA/uPAR expression in prostate cancer and stromal cells.
    Koochekpour S; Sartor O; Hiraiwa M; Lee TJ; Rayford W; Remmel N; Sandhoff K; Minokadeh A; Patten DY
    Asian J Androl; 2005 Jun; 7(2):147-58. PubMed ID: 15897971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue.
    Giangreco AA; Vaishnav A; Wagner D; Finelli A; Fleshner N; Van der Kwast T; Vieth R; Nonn L
    Cancer Prev Res (Phila); 2013 May; 6(5):483-94. PubMed ID: 23503652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Vitamin D3 metabolism enhances VDR signalling in androgen-independent prostate cancer cells.
    Yee SW; Campbell MJ; Simons C
    J Steroid Biochem Mol Biol; 2006 Mar; 98(4-5):228-35. PubMed ID: 16483768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase.
    Singh SV; Choi S; Zeng Y; Hahm ER; Xiao D
    Cancer Res; 2007 Aug; 67(15):7439-49. PubMed ID: 17671214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ; Peehl DM; Feldman D
    Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
    Ikezoe T; Gery S; Yin D; O'Kelly J; Binderup L; Lemp N; Taguchi H; Koeffler HP
    Cancer Res; 2005 Jun; 65(11):4762-8. PubMed ID: 15930295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.